# Augusto Vaglio

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/augusto-vaglio/

## Facts

| Field | Value |
| --- | --- |
| Citations | 50 |
| Field | Histiocytic Disorders and Treatments |
| h-index | 4 |
| i10-index | 1 |
| Last Known Institution | Sorbonne Université |
| OpenAlex ID | https://openalex.org/A5111213113 |
| Works | 15 |

## Researcher papers

- [Long-term outcome and prognosis of mixed histiocytosis (Erdheim-Chester disease and Langerhans Cell Histiocytosis)](https://scholariq.org/papers/long-term-outcome-and-prognosis-of-mixed-histiocytosis-erdheim-chester-disease/)
- [Treatment holidays in patients with Erdheim-Chester disease receiving vemurafenib: a prospective pilot study](https://scholariq.org/papers/treatment-holidays-in-patients-with-erdheim-chester-disease-receiving/)
- [MEK inhibitors are effective in Erdheim–Chester disease regardless of MAPK pathway mutations](https://scholariq.org/papers/mek-inhibitors-are-effective-in-erdheim-chester-disease-regardless-of-mapk/)
- [New Treatment Regimens, New Drugs, and New Treatment Goals for Lupus Nephritis](https://scholariq.org/papers/new-treatment-regimens-new-drugs-and-new-treatment-goals-for-lupus-nephritis/)
- [Anakinra improves retention rate of targeted treatments in Erdheim–Chester disease](https://scholariq.org/papers/anakinra-improves-retention-rate-of-targeted-treatments-in-erdheim-chester/)
- [Predictors of remission and relapse in retroperitoneal fibrosis](https://scholariq.org/papers/predictors-of-remission-and-relapse-in-retroperitoneal-fibrosis/)
- [Risk of Second Cancer in Erdheim-Chester Disease](https://scholariq.org/papers/risk-of-second-cancer-in-erdheim-chester-disease/)
- [IgG4-related kidney disease: from renal histopathology and immunopathogenesis to novel pharmacological interventions](https://scholariq.org/papers/igg4-related-kidney-disease-from-renal-histopathology-and-immunopathogenesis-to/)
- [EGPAware: a European Delphi consensus study on red flags for suspicion of eosinophilic granulomatosis with polyangiitis](https://scholariq.org/papers/egpaware-a-european-delphi-consensus-study-on-red-flags-for-suspicion-of/)
- [NIH Activity and Chronicity Indices in Lupus Nephritis: A Critical Analysis](https://scholariq.org/papers/nih-activity-and-chronicity-indices-in-lupus-nephritis-a-critical-analysis/)

## Researcher topics

- [Histiocytic Disorders and Treatments](https://scholariq.org/topics/histiocytic-disorders-and-treatments/)
- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Myeloproliferative Neoplasms: Diagnosis and Treatment](https://scholariq.org/topics/myeloproliferative-neoplasms-diagnosis-and-treatment/)
- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)
- [Sarcoidosis and Beryllium Toxicity Research](https://scholariq.org/topics/sarcoidosis-and-beryllium-toxicity-research/)

## Researcher university

- [Sorbonne Université](https://scholariq.org/institutions/sorbonne-universite/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.